SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001595585-21-000153
Filing Date
2021-12-21
Accepted
2021-12-21 19:20:11
Documents
1
Period of Report
2021-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164013239540935.html 4  
1 FORM 4 wf-form4_164013239540935.xml 4 11536
  Complete submission text file 0001595585-21-000153.txt   12936
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRICIDA, INC. 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address
COUFAL SANDRA I (Reporting) CIK: 0001744280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 211510645